The linkedin page contains this into:
About us
Praxgen Pharmaceuticals, formerly SunGen Pharma, was founded in 2016 by a team of distinguished pharma executives. Praxgen reflects our commitment to a practical and accessible path to patient health through high-quality generic pharmaceuticals.
Arthur Pharmaceutical Co., Ltd. was founded in March 2020. An established pharmaceutical company is focusing on complex generic drug development and production. Our newly established injection facility complies with FDA cGMP and China GMP requirements. Currently, more than 30 products are under development.
Arthur Group LLC, our subsidiary company, is located in New Jersey, with its main business on regulatory filing and US Market distribution.
Stage I: Arthur Pharma covers an area of 5600m² for its R&D center, which includes four teams, the API department, OSD formulation department, Injection formulation department, and R&D department. Our R&D team is located in Jiaxing, Zhejiang, China.
Stage II: Arthur Pharma is establishing an injectable facility with an area of 33,000 m². It is planned to produce different injection products, including oncology products, pre-fill syringe products, and ordinary injection products. Our solid oral product manufacturing lines are in the design stage.
To know more, please visit our website:
https://praxgen.com/
http://en.arthurpharma.com/
- Forums
- ASX - By Stock
- AVE
- News: AVE Avecho Biotechnology Signs Licensing And Development Agreement With Arthur Group Llc
News: AVE Avecho Biotechnology Signs Licensing And Development Agreement With Arthur Group Llc, page-8
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.038K | 679.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39212937 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.002 |
33 | 76717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39213112 | 30 |
0.004 | 30014232 | 16 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online